Mortality in the Highly Active Antiretroviral Therapy Era: Changing Causes of Death and Disease in the HIV Outpatient Study
By F. Palella, R. Baker, A. Moorman, J. Chmiel, K. Wood, J. Brooks, S. Holmberg. Journal of Acquired Immune Deficiency Syndromes, 2006
1,499 citations recorded by the source corpus.
Subfields: Emergency Medicine, Infectious Diseases
View Paper: https://www.semanticscholar.org/paper/bfcbba7554f8e0238433f5af89b32256302f9f15
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- J. Sterne
- G. Guaraldi
- Ross J. Harris
- J. Gill
- Kathleen N. Ly
- M. May
- F. Palella
- G. Orlando
Citations in the corpus
- Causes of Death in HIV-1–Infected Patients Treated with Antiretroviral Therapy, 1996–2006: Collaborative Analysis of 13 HIV Cohort Studies (2010, background): “tralia [20], 46% in the United Kingdom [21], to 50% in the United States [22].”
- The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007 (2012, background): “Department of Health and Human Services (19, 38).”
- Premature age-related comorbidities among HIV-infected persons compared with the general population. (2011, background): “multiple hypotheses have been made to explain the premature aging that is thought to occur among HIV-infected persons, particularly those for whomART is delayed until more advanced stages of immunodepletion and for whom more long-term chronic exposure to HIV viremia occurs [11, 31].”